Stocks and Investing Stocks and Investing
Fri, April 21, 2023

David Nierengarten Reiterated (ARGX) at Buy and Held Target at $432 on, Apr 21st, 2023


Published on 2024-10-28 02:56:21 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Reiterated "argenx SE" (ARGX) at Buy and Held Target at $432 on, Apr 21st, 2023.

David has made no other calls on ARGX in the last 4 months.



There are 6 other peers that have a rating on ARGX. Out of the 6 peers that are also analyzing ARGX, 0 agree with David's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with David


  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $482 on, Monday, March 20th, 2023
  • Roy Buchanan of "JMP Securities" Maintained at Buy with Increased Target to $448 on, Friday, March 3rd, 2023
  • Thomas Smith of "SVB Leerink" Maintained at Buy with Increased Target to $435 on, Friday, March 3rd, 2023
  • Allison Bratzel of "Piper Sandler" Maintained at Buy with Increased Target to $475 on, Thursday, February 23rd, 2023
  • Yaron Werber of "Cowen & Co." Maintained at Buy with Increased Target to $458 on, Wednesday, January 25th, 2023
  • Alex Thompson of "Stifel" Maintained at Strong Buy with Increased Target to $478 on, Thursday, December 22nd, 2022

Contributing Sources